Skip to main content
Aprogen, Inc logo

Aprogen, Inc — Investor Relations & Filings

Ticker · 007460 ISIN · KR7007460009 KO Manufacturing
Open in API
Filings indexed 737 across all filing types
Latest filing 2020-12-01 Major Shareholding Noti…
Country KR South Korea
Listing KO 007460

About Aprogen, Inc

https://www.aprogen.com/en/v.do?a=Main

Aprogen, Inc. is a biopharmaceutical company focused on the research, development, and manufacturing of biologic medicines. The company's core activities are centered on developing both biosimilars and novel drugs, including new protein therapeutics and bispecific antibodies. Its product development is based on proprietary technologies in antibody engineering and recombinant protein engineering.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, including convertible bonds and call options, by a major shareholder and their special related parties. This document type is specifically used to notify the market of significant changes in shareholding thresholds, which corresponds to the 'Major Shareholding Notification' category.
2020-12-01 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as the '5% Rule' report). It details changes in share ownership, including convertible bonds and special relationships, filed with the Financial Services Commission and the Korea Exchange. This falls under the category of Major Shareholding Notification.
2020-11-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service and Korea Exchange. This type of filing is a standard regulatory disclosure in South Korea used when a major shareholder or executive changes their stake in a company. While it involves share ownership, it is specifically a regulatory disclosure of insider/major shareholder holdings rather than a 'Director's Dealing' (which usually refers to individual trades) or 'Major Shareholding Notification' (which is a broader threshold disclosure). Given the specific regulatory nature and the provided categories, it fits best under 'Regulatory Filings' as a fallback for this specific Korean regulatory form.
2020-11-26 Korean
[기재정정]감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing titled '감사보고서 제출' (Submission of Audit Report) which serves as a correction (정정신고) to a previously submitted audit report. It provides updated financial figures (assets, liabilities, equity, net income) for both consolidated and separate financial statements. Since it is a formal regulatory announcement regarding the submission and correction of audit-related financial data, it falls under the 'Audit Report / Information' category. FY 2019
2020-11-13 Korean
[기재정정]사업보고서 (2019.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Correction Report' (정정신고) for an Audit Report (감사보고서) originally filed on March 11, 2020. It details specific corrections to financial statements (Balance Sheet, Income Statement, Statement of Changes in Equity) and notes due to adjustments in deferred tax recognition. Since this is a standalone document providing audit-related financial corrections rather than a full annual report or a simple announcement of a report, it falls under the Audit Report/Information category. FY 2019
2020-11-13 Korean
[기재정정]분기보고서 (2020.03)
Interim / Quarterly Report Classification · 95% confidence The document is a formal 'Correction Report' (정정신고) for a previously filed Quarterly Report (분기보고서). It explicitly lists the items being corrected, including financial statements, balance sheets, and equity tables, and provides the 'before' and 'after' data for these specific sections. Since it contains substantive financial data and is a correction to an existing interim/quarterly report, it is classified as an Interim/Quarterly Report (IR) filing. Q1 2020
2020-11-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.